These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Synthesis and binding properties of cyclopentane analogues of myo-inositol 1,4,5-tris(phosphate). Moris MA; Caron AZ; Guillemette G; Schlewer G Bioorg Med Chem; 2004 Aug; 12(15):3995-4001. PubMed ID: 15246076 [TBL] [Abstract][Full Text] [Related]
3. Synthesis of (+/-)-2-O-[4'-(N-9''-purinyl)butyl] myo-inositol 1,4,5-tris(phosphate), a potent full agonist at the D-myo-inositol 1,4,5-tris(phosphate) receptor. Moris MA; Caron AZ; Guillemette G; Rognan D; Schmitt M; Schlewer G J Med Chem; 2005 Feb; 48(4):1251-5. PubMed ID: 15715492 [TBL] [Abstract][Full Text] [Related]
4. 2-O-(2-Aminoethyl)-myo-inositol 1,4,5-trisphosphate as a novel ligand for conjugation: physicochemical properties and synthesis of a new Ins(1,4,5)P(3) affinity matrix. Riley AM; Dozol H; Spiess B; Potter BV Biochem Biophys Res Commun; 2004 May; 318(2):444-52. PubMed ID: 15120621 [TBL] [Abstract][Full Text] [Related]
5. Dimers of D-myo-inositol 1,4,5-trisphosphate: design, synthesis, and interaction with Ins(1,4,5)P3 receptors. Riley AM; Laude AJ; Taylor CW; Potter BV Bioconjug Chem; 2004; 15(2):278-89. PubMed ID: 15025523 [TBL] [Abstract][Full Text] [Related]
6. D-myo-inositol 1,4,5-trisphosphate analogues modified at the 3-position inhibit phosphatidylinositol 3-kinase. Ward SG; Mills SJ; Liu C; Westwick J; Potter BV J Biol Chem; 1995 May; 270(20):12075-84. PubMed ID: 7744856 [TBL] [Abstract][Full Text] [Related]
7. Synthesis, acid-base behavior, and binding properties of 6-modified myo-inositol 1,4,5-tris(phosphate)s. Ballereau S; Guédat P; Poirier SN; Guillemette G; Spiess B; Schlewer G J Med Chem; 1999 Nov; 42(23):4824-35. PubMed ID: 10579845 [TBL] [Abstract][Full Text] [Related]
14. Interaction of the catalytic domain of inositol 1,4,5-trisphosphate 3-kinase A with inositol phosphate analogues. Poinas A; Backers K; Riley AM; Mills SJ; Moreau C; Potter BV; Erneux C Chembiochem; 2005 Aug; 6(8):1449-57. PubMed ID: 15997461 [TBL] [Abstract][Full Text] [Related]
15. Synthesis and biological action of novel 4-position-modified derivatives of D-myo-inositol 1,4,5-trisphosphate. Bello D; Aslam T; Bultynck G; Slawin AM; Roderick HL; Bootman MD; Conway SJ J Org Chem; 2007 Jul; 72(15):5647-59. PubMed ID: 17585817 [TBL] [Abstract][Full Text] [Related]
16. Synthesis and biological properties of 2-substituted myo-inositol 1,4,5-trisphosphate analogues directed toward affinity chromatography and photoaffinity labeling. Ozaki S; Watanabe Y; Ogasawara T; Hirata M; Kanematsu T Carbohydr Res; 1992 Oct; 234():189-206. PubMed ID: 1468078 [TBL] [Abstract][Full Text] [Related]
17. 2-Position base-modified analogues of adenophostin A as high-affinity agonists of the D-myo-inositol trisphosphate receptor: in vitro evaluation and molecular modeling. Sureshan KM; Trusselle M; Tovey SC; Taylor CW; Potter BV J Org Chem; 2008 Mar; 73(5):1682-92. PubMed ID: 18247493 [TBL] [Abstract][Full Text] [Related]
18. Simultaneous determination of inositol and inositol phosphates in complex biological matrices: quantitative ion-exchange chromatography/tandem mass spectrometry. Liu X; Villalta PW; Sturla SJ Rapid Commun Mass Spectrom; 2009 Mar; 23(5):705-12. PubMed ID: 19191261 [TBL] [Abstract][Full Text] [Related]
19. Synthesis of analogues of myo-inositol 1,4,5-trisphosphate that contain sulfonamide, sulfate, methylphosphonate, and carboxymethyl groups. Westerduin P; Willems HA; van Boeckel CA Carbohydr Res; 1992 Oct; 234():131-40. PubMed ID: 1334798 [TBL] [Abstract][Full Text] [Related]
20. Development of inositol-based antagonists for the D-myo-inositol 1,4,5-trisphosphate receptor. Keddie NS; Ye Y; Aslam T; Luyten T; Bello D; Garnham C; Bultynck G; Galione A; Conway SJ Chem Commun (Camb); 2011 Jan; 47(1):242-4. PubMed ID: 20938532 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]